title: New biomarkers in an acute model of live Escherichia coli-induced sepsis in pigs.
abstract: We developed a live Escherichia coli model of acute sepsis in pigs with emphasize on biomarkers reflecting the early inflammatory response of sepsis. Healthy pigs, 25-35 kg, were challenged intravenously (IV) (n = 12) or intrapulmonary (n = 6) with live E. coli and observed for 3 and 5 h respectively. Control pigs received culture medium (n = 6 + 3). Haemodynamic parameters and a broad panel of inflammatory mediators were measured. The dose of bacteria was carefully titrated to obtain a condition resembling the early phase of human septic shock. The IV group displayed a pro-inflammatory response [significant increase in tumour necrosis factor-alpha, interleukin (IL)-6 and IL-8] and an early anti-inflammatory response (significant increase in IL-10). For the first time, we demonstrate a significant increase in IL-12 and matrix metalloproteinase-9 (MMP) early in pig sepsis. Coagulation was activated (significant increase in thrombin-antithrombin complexes) and there was a significant decrease in the serum proteins suggesting capillary leakage. Haemodynamic parameters reflected a septic condition with significant decrease in systemic blood pressure, increases in heart rate, pulmonary artery pressure and base deficit. None of these changes was observed in the control group. Interleukin-1beta and vascular endothelial growth factor increased in both groups. Nitric oxide measurements suggested an initial pulmonary vascular endothelial inflammatory response. The intrapulmonary group, which did not resemble septic condition, showed a substantial increase in MMP-9. In this porcine model of sepsis, IL-12 and MMP-9 were detected for the first time. These biomarkers may have an impact in the understanding and future treatment of sepsis.
authors.affiliation: Institute of Immunology, Rikshospitalet University Hospital, and University of Oslo, Oslo, Norway. albert.castellheim@medisin.uio.no
authors.forename: A
authors.initials: A
authors.lastname: Castellheim
authors.forename: E B
authors.initials: EB
authors.lastname: Thorgersen
authors.forename: B C
authors.initials: BC
authors.lastname: Hellerud
authors.forename: A
authors.initials: A
authors.lastname: Pharo
authors.forename: H T
authors.initials: HT
authors.lastname: Johansen
authors.forename: F
authors.initials: F
authors.lastname: Brosstad
authors.forename: P
authors.initials: P
authors.lastname: Gaustad
authors.forename: H
authors.initials: H
authors.lastname: Brun
authors.forename: E
authors.initials: E
authors.lastname: Fosse
authors.forename: T I
authors.initials: TI
authors.lastname: Tønnessen
authors.forename: E W
authors.initials: EW
authors.lastname: Nielsen
authors.forename: T E
authors.initials: TE
authors.lastname: Mollnes
mesh_terms: D000818:Animals; D015415:Biomarkers / Q000097:blood*; D004195:Disease Models, Animal; D004926:Escherichia coli; D006439:Hemodynamics; D018836:Inflammation Mediators / Q000097:blood*; D018664:Interleukin-12 / Q000097:blood; D020780:Matrix Metalloproteinase 9 / Q000097:blood; D018805:Sepsis / Q000097:blood* / Q000276:immunology / Q000503:physiopathology*; D013552:Swine
chemical_list: D015415:Biomarkers; D018836:Inflammation Mediators; D018664:Interleukin-12; D020780:Matrix Metalloproteinase 9